| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,983,226 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Trizzino John |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-07 |
4 |
AS |
$176.60 |
$33,559 |
D/D |
(190) |
287 |
|
- |
|
| Trizzino John |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
D |
$171.74 |
$30,913 |
D/D |
(180) |
477 |
|
- |
|
| Trizzino John |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
D |
$171.74 |
$2,404 |
D/D |
(14) |
657 |
|
- |
|
| Trizzino John |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
OE |
$5.95 |
$50,160 |
D/D |
3,406 |
671 |
|
- |
|
| Trizzino John |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
AS |
$163.03 |
$560,471 |
D/D |
(3,022) |
287 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-04-30 |
4 |
AS |
$236.27 |
$694,317 |
D/D |
(2,895) |
275 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-04-30 |
4 |
OE |
$5.95 |
$42,892 |
D/D |
2,895 |
3,170 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-04-19 |
4 |
AS |
$213.79 |
$531,052 |
D/D |
(2,417) |
2,811 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-04-15 |
4 |
D |
$202.09 |
$456,723 |
D/D |
(2,260) |
5,228 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-04-15 |
4 |
D |
$202.09 |
$28,697 |
D/D |
(142) |
7,488 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-04-15 |
4 |
OE |
$5.95 |
$1,083,775 |
D/D |
10,531 |
7,630 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-04-15 |
4 |
AS |
$196.77 |
$1,144,387 |
D/D |
(5,712) |
2,811 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-04-07 |
4 |
AS |
$178.03 |
$34,004 |
D/D |
(191) |
287 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
D |
$177.29 |
$31,735 |
D/D |
(179) |
478 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
D |
$177.29 |
$2,305 |
D/D |
(13) |
657 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
OE |
$5.95 |
$115,771 |
D/D |
3,404 |
670 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
AS |
$190.10 |
$574,292 |
D/D |
(3,021) |
287 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-03-26 |
4 |
AS |
$181.09 |
$540,609 |
D/D |
(2,894) |
275 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-03-26 |
4 |
OE |
$5.95 |
$42,887 |
D/D |
2,894 |
3,169 |
|
- |
|
| Young James F |
Director |
– • – |
2021-03-25 |
4 |
OE |
$3.99 |
$425,438 |
D/D |
47,500 |
57,500 |
|
- |
|
| Young James F |
Director |
– • – |
2021-03-23 |
4 |
S |
$227.43 |
$2,282,231 |
D/D |
(10,000) |
10,000 |
|
- |
|
| Young James F |
Director |
– • – |
2021-03-23 |
4 |
OE |
$46.00 |
$460,000 |
D/D |
10,000 |
20,000 |
|
- |
|
| Mcmanus Michael A Jr |
Director |
– • – |
2021-03-19 |
4 |
S |
$220.57 |
$883,110 |
D/D |
(4,000) |
5,951 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-03-17 |
4 |
AS |
$210.85 |
$530,304 |
D/D |
(2,423) |
2,811 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-03-15 |
4 |
D |
$217.46 |
$492,329 |
D/D |
(2,264) |
5,234 |
|
- |
|
602 Records found
|
|
Page 10 of 25 |
|
|
